CD271 is also called p75 neurotmphin receptor (p75NTR), and in ESCC, cells expressing CD271 were reported to have higher self-amplifying and self-renewal capacities than cells not expressing CD271 [26]. This evidence concerns the gene NGFR and esophageal squamous cell carcinoma.